About this trial
Among patients who have undergone EVAR, there is a significant risk of 20-50% endoleak. These endoleaks often require secondary interventions to reduce the risk of expansion or rupture. Currently, three-phase CT angiography and CEUS ultrasound are recommended in the post-operative monitoring of EVAR but these remain limited in characterizing the type and source of endoleak. In this study the investigators will study the interest of d-CTA for a better detection and characterization of endoleaks.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients 18 years of age and older,
Patients who have received EVAR ,
Detection of endoleak and/or with an aneurysmal sac enlargement greater than or equal to 5 mm over 6 months.
Disqualifiers
Minor patients,
absence of endoleak and growth of the aneurysmal sac (greater than or equal to 5 mm over 6 months),
patient under guardianship, curators, safeguard of justice,
patient deprived of liberty,
Trial design
Single group
Treatments tested in this trial
three-phase CT angiography
Other interventionthree-phase CT angiography
CEUS ultrasound
Other interventionCEUS ultrasound
Treatment groups
Trial outcomes
Primary outcomes
Endoleak classification using the CT angiography
Endoleak classification using the CT angiography
Variation of Endoleak classification between CEUS ultrasound and the CT angiography
Variation of Endoleak classification between CEUS ultrasound and the CT angiography
Sponsors and contacts
Click on the lead sponsor to view all of their trials.